The global Combined Hormonal Contraceptives market was valued at US$ 17780 million in 2023 and is anticipated to reach US$ 22360 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

Combined Hormonal Contraceptives Market

Combined hormonal contraceptives are used to prevent pregnancies. They are also used in the treatment of acne vulgaris, endometriosis, polycystic ovarian syndrome, and irregular menstrual flow by blocking ovulation. These products are widely used by women of aged between 15 and 49 years.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Combined Hormonal Contraceptives, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Combined Hormonal Contraceptives.

Report Scope

The Combined Hormonal Contraceptives market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Combined Hormonal Contraceptives market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Combined Hormonal Contraceptives manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Combined Hormonal Contraceptives Market Report

Report Metric	Details
Report Name	Combined Hormonal Contraceptives Market
Accounted market size in 2023	US$ 17780 million
Forecasted market size in 2030	US$ 22360 million
CAGR	3.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	15-24 years 25-34 years 35-44 years Above 44 years
Segment by Application	Hospital Pharmacy Retail Pharmacy Online Pharmacy
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Actavis, Agile Therapeutics, Allergan, Bayer, Teva Pharmaceutical Industries, ANI Pharmaceuticals, Ortho-McNeil-Janssen Pharmaceuticals, Noven Pharmaceuticals, Johnson & Johnson, Mylan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Combined Hormonal Contraceptives manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Combined Hormonal Contraceptives in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Combined Hormonal Contraceptives Market growing?

Ans: The Combined Hormonal Contraceptives Market witnessing a CAGR of 3.3% during the forecast period 2024-2030.

What is the Combined Hormonal Contraceptives Market size in 2030?

Ans: The Combined Hormonal Contraceptives Market size in 2030 will be US$ 22360 million.

Who are the main players in the Combined Hormonal Contraceptives Market report?

Ans: The main players in the Combined Hormonal Contraceptives Market are Actavis, Agile Therapeutics, Allergan, Bayer, Teva Pharmaceutical Industries, ANI Pharmaceuticals, Ortho-McNeil-Janssen Pharmaceuticals, Noven Pharmaceuticals, Johnson & Johnson, Mylan

What are the Application segmentation covered in the Combined Hormonal Contraceptives Market report?

Ans: The Applications covered in the Combined Hormonal Contraceptives Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

What are the Type segmentation covered in the Combined Hormonal Contraceptives Market report?

Ans: The Types covered in the Combined Hormonal Contraceptives Market report are 15-24 years, 25-34 years, 35-44 years, Above 44 years

1 Combined Hormonal Contraceptives Market Overview

1.1 Product Overview and Scope of Combined Hormonal Contraceptives

1.2 Combined Hormonal Contraceptives Segment by Type

1.2.1 Global Combined Hormonal Contraceptives Market Value Comparison by Type (2024-2030)

1.2.2 15-24 years

1.2.3 25-34 years

1.2.4 35-44 years

1.2.5 Above 44 years

1.3 Combined Hormonal Contraceptives Segment by Application

1.3.1 Global Combined Hormonal Contraceptives Market Value by Application: (2024-2030)

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.4 Global Combined Hormonal Contraceptives Market Size Estimates and Forecasts

1.4.1 Global Combined Hormonal Contraceptives Revenue 2019-2030

1.4.2 Global Combined Hormonal Contraceptives Sales 2019-2030

1.4.3 Global Combined Hormonal Contraceptives Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Combined Hormonal Contraceptives Market Competition by Manufacturers

2.1 Global Combined Hormonal Contraceptives Sales Market Share by Manufacturers (2019-2024)

2.2 Global Combined Hormonal Contraceptives Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Combined Hormonal Contraceptives Average Price by Manufacturers (2019-2024)

2.4 Global Combined Hormonal Contraceptives Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Combined Hormonal Contraceptives, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Combined Hormonal Contraceptives, Product Type & Application

2.7 Combined Hormonal Contraceptives Market Competitive Situation and Trends

2.7.1 Combined Hormonal Contraceptives Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Combined Hormonal Contraceptives Players Market Share by Revenue

2.7.3 Global Combined Hormonal Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Combined Hormonal Contraceptives Retrospective Market Scenario by Region

3.1 Global Combined Hormonal Contraceptives Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Combined Hormonal Contraceptives Global Combined Hormonal Contraceptives Sales by Region: 2019-2030

3.2.1 Global Combined Hormonal Contraceptives Sales by Region: 2019-2024

3.2.2 Global Combined Hormonal Contraceptives Sales by Region: 2025-2030

3.3 Global Combined Hormonal Contraceptives Global Combined Hormonal Contraceptives Revenue by Region: 2019-2030

3.3.1 Global Combined Hormonal Contraceptives Revenue by Region: 2019-2024

3.3.2 Global Combined Hormonal Contraceptives Revenue by Region: 2025-2030

3.4 North America Combined Hormonal Contraceptives Market Facts & Figures by Country

3.4.1 North America Combined Hormonal Contraceptives Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Combined Hormonal Contraceptives Sales by Country (2019-2030)

3.4.3 North America Combined Hormonal Contraceptives Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Combined Hormonal Contraceptives Market Facts & Figures by Country

3.5.1 Europe Combined Hormonal Contraceptives Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Combined Hormonal Contraceptives Sales by Country (2019-2030)

3.5.3 Europe Combined Hormonal Contraceptives Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Combined Hormonal Contraceptives Market Facts & Figures by Country

3.6.1 Asia Pacific Combined Hormonal Contraceptives Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Combined Hormonal Contraceptives Sales by Country (2019-2030)

3.6.3 Asia Pacific Combined Hormonal Contraceptives Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Combined Hormonal Contraceptives Market Facts & Figures by Country

3.7.1 Latin America Combined Hormonal Contraceptives Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Combined Hormonal Contraceptives Sales by Country (2019-2030)

3.7.3 Latin America Combined Hormonal Contraceptives Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Combined Hormonal Contraceptives Market Facts & Figures by Country

3.8.1 Middle East and Africa Combined Hormonal Contraceptives Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Combined Hormonal Contraceptives Sales by Country (2019-2030)

3.8.3 Middle East and Africa Combined Hormonal Contraceptives Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Combined Hormonal Contraceptives Sales by Type (2019-2030)

4.1.1 Global Combined Hormonal Contraceptives Sales by Type (2019-2024)

4.1.2 Global Combined Hormonal Contraceptives Sales by Type (2025-2030)

4.1.3 Global Combined Hormonal Contraceptives Sales Market Share by Type (2019-2030)

4.2 Global Combined Hormonal Contraceptives Revenue by Type (2019-2030)

4.2.1 Global Combined Hormonal Contraceptives Revenue by Type (2019-2024)

4.2.2 Global Combined Hormonal Contraceptives Revenue by Type (2025-2030)

4.2.3 Global Combined Hormonal Contraceptives Revenue Market Share by Type (2019-2030)

4.3 Global Combined Hormonal Contraceptives Price by Type (2019-2030)

5 Segment by Application

5.1 Global Combined Hormonal Contraceptives Sales by Application (2019-2030)

5.1.1 Global Combined Hormonal Contraceptives Sales by Application (2019-2024)

5.1.2 Global Combined Hormonal Contraceptives Sales by Application (2025-2030)

5.1.3 Global Combined Hormonal Contraceptives Sales Market Share by Application (2019-2030)

5.2 Global Combined Hormonal Contraceptives Revenue by Application (2019-2030)

5.2.1 Global Combined Hormonal Contraceptives Revenue by Application (2019-2024)

5.2.2 Global Combined Hormonal Contraceptives Revenue by Application (2025-2030)

5.2.3 Global Combined Hormonal Contraceptives Revenue Market Share by Application (2019-2030)

5.3 Global Combined Hormonal Contraceptives Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Actavis

6.1.1 Actavis Corporation Information

6.1.2 Actavis Description and Business Overview

6.1.3 Actavis Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Actavis Combined Hormonal Contraceptives Product Portfolio

6.1.5 Actavis Recent Developments/Updates

6.2 Agile Therapeutics

6.2.1 Agile Therapeutics Corporation Information

6.2.2 Agile Therapeutics Description and Business Overview

6.2.3 Agile Therapeutics Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Agile Therapeutics Combined Hormonal Contraceptives Product Portfolio

6.2.5 Agile Therapeutics Recent Developments/Updates

6.3 Allergan

6.3.1 Allergan Corporation Information

6.3.2 Allergan Description and Business Overview

6.3.3 Allergan Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Allergan Combined Hormonal Contraceptives Product Portfolio

6.3.5 Allergan Recent Developments/Updates

6.4 Bayer

6.4.1 Bayer Corporation Information

6.4.2 Bayer Description and Business Overview

6.4.3 Bayer Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Bayer Combined Hormonal Contraceptives Product Portfolio

6.4.5 Bayer Recent Developments/Updates

6.5 Teva Pharmaceutical Industries

6.5.1 Teva Pharmaceutical Industries Corporation Information

6.5.2 Teva Pharmaceutical Industries Description and Business Overview

6.5.3 Teva Pharmaceutical Industries Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Teva Pharmaceutical Industries Combined Hormonal Contraceptives Product Portfolio

6.5.5 Teva Pharmaceutical Industries Recent Developments/Updates

6.6 ANI Pharmaceuticals

6.6.1 ANI Pharmaceuticals Corporation Information

6.6.2 ANI Pharmaceuticals Description and Business Overview

6.6.3 ANI Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)

6.6.4 ANI Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio

6.6.5 ANI Pharmaceuticals Recent Developments/Updates

6.7 Ortho-McNeil-Janssen Pharmaceuticals

6.6.1 Ortho-McNeil-Janssen Pharmaceuticals Corporation Information

6.6.2 Ortho-McNeil-Janssen Pharmaceuticals Description and Business Overview

6.6.3 Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio

6.7.5 Ortho-McNeil-Janssen Pharmaceuticals Recent Developments/Updates

6.8 Noven Pharmaceuticals

6.8.1 Noven Pharmaceuticals Corporation Information

6.8.2 Noven Pharmaceuticals Description and Business Overview

6.8.3 Noven Pharmaceuticals Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Noven Pharmaceuticals Combined Hormonal Contraceptives Product Portfolio

6.8.5 Noven Pharmaceuticals Recent Developments/Updates

6.9 Johnson & Johnson

6.9.1 Johnson & Johnson Corporation Information

6.9.2 Johnson & Johnson Description and Business Overview

6.9.3 Johnson & Johnson Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Johnson & Johnson Combined Hormonal Contraceptives Product Portfolio

6.9.5 Johnson & Johnson Recent Developments/Updates

6.10 Mylan

6.10.1 Mylan Corporation Information

6.10.2 Mylan Description and Business Overview

6.10.3 Mylan Combined Hormonal Contraceptives Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Mylan Combined Hormonal Contraceptives Product Portfolio

6.10.5 Mylan Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Combined Hormonal Contraceptives Industry Chain Analysis

7.2 Combined Hormonal Contraceptives Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Combined Hormonal Contraceptives Production Mode & Process

7.4 Combined Hormonal Contraceptives Sales and Marketing

7.4.1 Combined Hormonal Contraceptives Sales Channels

7.4.2 Combined Hormonal Contraceptives Distributors

7.5 Combined Hormonal Contraceptives Customers

8 Combined Hormonal Contraceptives Market Dynamics

8.1 Combined Hormonal Contraceptives Industry Trends

8.2 Combined Hormonal Contraceptives Market Drivers

8.3 Combined Hormonal Contraceptives Market Challenges

8.4 Combined Hormonal Contraceptives Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Teva Pharmaceutical Industries

ANI Pharmaceuticals

Ortho-McNeil-Janssen Pharmaceuticals

Noven Pharmaceuticals

Johnson & Johnson

Mylan NV

List of Tables

Table 1. Global Combined Hormonal Contraceptives Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Combined Hormonal Contraceptives Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Combined Hormonal Contraceptives Market Competitive Situation by Manufacturers in 2023

Table 4. Global Combined Hormonal Contraceptives Sales (Units) of Key Manufacturers (2019-2024)

Table 5. Global Combined Hormonal Contraceptives Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Combined Hormonal Contraceptives Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Combined Hormonal Contraceptives Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Combined Hormonal Contraceptives Average Price (USD/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Combined Hormonal Contraceptives, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Combined Hormonal Contraceptives, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Combined Hormonal Contraceptives, Product Type & Application

Table 12. Global Key Manufacturers of Combined Hormonal Contraceptives, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Combined Hormonal Contraceptives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Combined Hormonal Contraceptives as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Combined Hormonal Contraceptives Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Combined Hormonal Contraceptives Sales by Region (2019-2024) & (Units)

Table 18. Global Combined Hormonal Contraceptives Sales Market Share by Region (2019-2024)

Table 19. Global Combined Hormonal Contraceptives Sales by Region (2025-2030) & (Units)

Table 20. Global Combined Hormonal Contraceptives Sales Market Share by Region (2025-2030)

Table 21. Global Combined Hormonal Contraceptives Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Combined Hormonal Contraceptives Revenue Market Share by Region (2019-2024)

Table 23. Global Combined Hormonal Contraceptives Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Combined Hormonal Contraceptives Revenue Market Share by Region (2025-2030)

Table 25. North America Combined Hormonal Contraceptives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Combined Hormonal Contraceptives Sales by Country (2019-2024) & (Units)

Table 27. North America Combined Hormonal Contraceptives Sales by Country (2025-2030) & (Units)

Table 28. North America Combined Hormonal Contraceptives Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Combined Hormonal Contraceptives Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Combined Hormonal Contraceptives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Combined Hormonal Contraceptives Sales by Country (2019-2024) & (Units)

Table 32. Europe Combined Hormonal Contraceptives Sales by Country (2025-2030) & (Units)

Table 33. Europe Combined Hormonal Contraceptives Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Combined Hormonal Contraceptives Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Combined Hormonal Contraceptives Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Combined Hormonal Contraceptives Sales by Region (2019-2024) & (Units)

Table 37. Asia Pacific Combined Hormonal Contraceptives Sales by Region (2025-2030) & (Units)

Table 38. Asia Pacific Combined Hormonal Contraceptives Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Combined Hormonal Contraceptives Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Combined Hormonal Contraceptives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Combined Hormonal Contraceptives Sales by Country (2019-2024) & (Units)

Table 42. Latin America Combined Hormonal Contraceptives Sales by Country (2025-2030) & (Units)

Table 43. Latin America Combined Hormonal Contraceptives Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Combined Hormonal Contraceptives Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Combined Hormonal Contraceptives Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Combined Hormonal Contraceptives Sales by Country (2019-2024) & (Units)

Table 47. Middle East & Africa Combined Hormonal Contraceptives Sales by Country (2025-2030) & (Units)

Table 48. Middle East & Africa Combined Hormonal Contraceptives Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Combined Hormonal Contraceptives Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Combined Hormonal Contraceptives Sales (Units) by Type (2019-2024)

Table 51. Global Combined Hormonal Contraceptives Sales (Units) by Type (2025-2030)

Table 52. Global Combined Hormonal Contraceptives Sales Market Share by Type (2019-2024)

Table 53. Global Combined Hormonal Contraceptives Sales Market Share by Type (2025-2030)

Table 54. Global Combined Hormonal Contraceptives Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Combined Hormonal Contraceptives Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Combined Hormonal Contraceptives Revenue Market Share by Type (2019-2024)

Table 57. Global Combined Hormonal Contraceptives Revenue Market Share by Type (2025-2030)

Table 58. Global Combined Hormonal Contraceptives Price (USD/Unit) by Type (2019-2024)

Table 59. Global Combined Hormonal Contraceptives Price (USD/Unit) by Type (2025-2030)

Table 60. Global Combined Hormonal Contraceptives Sales (Units) by Application (2019-2024)

Table 61. Global Combined Hormonal Contraceptives Sales (Units) by Application (2025-2030)

Table 62. Global Combined Hormonal Contraceptives Sales Market Share by Application (2019-2024)

Table 63. Global Combined Hormonal Contraceptives Sales Market Share by Application (2025-2030)

Table 64. Global Combined Hormonal Contraceptives Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Combined Hormonal Contraceptives Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Combined Hormonal Contraceptives Revenue Market Share by Application (2019-2024)

Table 67. Global Combined Hormonal Contraceptives Revenue Market Share by Application (2025-2030)

Table 68. Global Combined Hormonal Contraceptives Price (USD/Unit) by Application (2019-2024)

Table 69. Global Combined Hormonal Contraceptives Price (USD/Unit) by Application (2025-2030)

Table 70. Actavis Corporation Information

Table 71. Actavis Description and Business Overview

Table 72. Actavis Combined Hormonal Contraceptives Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 73. Actavis Combined Hormonal Contraceptives Product

Table 74. Actavis Recent Developments/Updates

Table 75. Agile Therapeutics Corporation Information

Table 76. Agile Therapeutics Description and Business Overview

Table 77. Agile Therapeutics Combined Hormonal Contraceptives Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 78. Agile Therapeutics Combined Hormonal Contraceptives Product

Table 79. Agile Therapeutics Recent Developments/Updates

Table 80. Allergan Corporation Information

Table 81. Allergan Description and Business Overview

Table 82. Allergan Combined Hormonal Contraceptives Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 83. Allergan Combined Hormonal Contraceptives Product

Table 84. Allergan Recent Developments/Updates

Table 85. Bayer Corporation Information

Table 86. Bayer Description and Business Overview

Table 87. Bayer Combined Hormonal Contraceptives Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 88. Bayer Combined Hormonal Contraceptives Product

Table 89. Bayer Recent Developments/Updates

Table 90. Teva Pharmaceutical Industries Corporation Information

Table 91. Teva Pharmaceutical Industries Description and Business Overview

Table 92. Teva Pharmaceutical Industries Combined Hormonal Contraceptives Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 93. Teva Pharmaceutical Industries Combined Hormonal Contraceptives Product

Table 94. Teva Pharmaceutical Industries Recent Developments/Updates

Table 95. ANI Pharmaceuticals Corporation Information

Table 96. ANI Pharmaceuticals Description and Business Overview

Table 97. ANI Pharmaceuticals Combined Hormonal Contraceptives Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 98. ANI Pharmaceuticals Combined Hormonal Contraceptives Product

Table 99. ANI Pharmaceuticals Recent Developments/Updates

Table 100. Ortho-McNeil-Janssen Pharmaceuticals Corporation Information

Table 101. Ortho-McNeil-Janssen Pharmaceuticals Description and Business Overview

Table 102. Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 103. Ortho-McNeil-Janssen Pharmaceuticals Combined Hormonal Contraceptives Product

Table 104. Ortho-McNeil-Janssen Pharmaceuticals Recent Developments/Updates

Table 105. Noven Pharmaceuticals Corporation Information

Table 106. Noven Pharmaceuticals Description and Business Overview

Table 107. Noven Pharmaceuticals Combined Hormonal Contraceptives Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 108. Noven Pharmaceuticals Combined Hormonal Contraceptives Product

Table 109. Noven Pharmaceuticals Recent Developments/Updates

Table 110. Johnson & Johnson Corporation Information

Table 111. Johnson & Johnson Description and Business Overview

Table 112. Johnson & Johnson Combined Hormonal Contraceptives Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 113. Johnson & Johnson Combined Hormonal Contraceptives Product

Table 114. Johnson & Johnson Recent Developments/Updates

Table 115. Mylan Corporation Information

Table 116. Mylan Description and Business Overview

Table 117. Mylan Combined Hormonal Contraceptives Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)

Table 118. Mylan Combined Hormonal Contraceptives Product

Table 119. Mylan Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Combined Hormonal Contraceptives Distributors List

Table 123. Combined Hormonal Contraceptives Customers List

Table 124. Combined Hormonal Contraceptives Market Trends

Table 125. Combined Hormonal Contraceptives Market Drivers

Table 126. Combined Hormonal Contraceptives Market Challenges

Table 127. Combined Hormonal Contraceptives Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Combined Hormonal Contraceptives

Figure 2. Global Combined Hormonal Contraceptives Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Combined Hormonal Contraceptives Market Share by Type in 2023 & 2030

Figure 4. 15-24 years Product Picture

Figure 5. 25-34 years Product Picture

Figure 6. 35-44 years Product Picture

Figure 7. Above 44 years Product Picture

Figure 8. Global Combined Hormonal Contraceptives Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Combined Hormonal Contraceptives Market Share by Application in 2023 & 2030

Figure 10. Hospital Pharmacy

Figure 11. Retail Pharmacy

Figure 12. Online Pharmacy

Figure 13. Global Combined Hormonal Contraceptives Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Combined Hormonal Contraceptives Market Size (2019-2030) & (US$ Million)

Figure 15. Global Combined Hormonal Contraceptives Sales (2019-2030) & (Units)

Figure 16. Global Combined Hormonal Contraceptives Average Price (USD/Unit) & (2019-2030)

Figure 17. Combined Hormonal Contraceptives Report Years Considered

Figure 18. Combined Hormonal Contraceptives Sales Share by Manufacturers in 2023

Figure 19. Global Combined Hormonal Contraceptives Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Combined Hormonal Contraceptives Players: Market Share by Revenue in 2023

Figure 21. Combined Hormonal Contraceptives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Combined Hormonal Contraceptives Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Combined Hormonal Contraceptives Sales Market Share by Country (2019-2030)

Figure 24. North America Combined Hormonal Contraceptives Revenue Market Share by Country (2019-2030)

Figure 25. U.S. Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Combined Hormonal Contraceptives Sales Market Share by Country (2019-2030)

Figure 28. Europe Combined Hormonal Contraceptives Revenue Market Share by Country (2019-2030)

Figure 29. Germany Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Combined Hormonal Contraceptives Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Combined Hormonal Contraceptives Revenue Market Share by Region (2019-2030)

Figure 36. China Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Taiwan Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Philippines Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Latin America Combined Hormonal Contraceptives Sales Market Share by Country (2019-2030)

Figure 47. Latin America Combined Hormonal Contraceptives Revenue Market Share by Country (2019-2030)

Figure 48. Mexico Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Brazil Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Argentina Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Middle East & Africa Combined Hormonal Contraceptives Sales Market Share by Country (2019-2030)

Figure 52. Middle East & Africa Combined Hormonal Contraceptives Revenue Market Share by Country (2019-2030)

Figure 53. Turkey Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. U.A.E Combined Hormonal Contraceptives Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 56. Global Sales Market Share of Combined Hormonal Contraceptives by Type (2019-2030)

Figure 57. Global Revenue Market Share of Combined Hormonal Contraceptives by Type (2019-2030)

Figure 58. Global Combined Hormonal Contraceptives Price (USD/Unit) by Type (2019-2030)

Figure 59. Global Sales Market Share of Combined Hormonal Contraceptives by Application (2019-2030)

Figure 60. Global Revenue Market Share of Combined Hormonal Contraceptives by Application (2019-2030)

Figure 61. Global Combined Hormonal Contraceptives Price (USD/Unit) by Application (2019-2030)

Figure 62. Combined Hormonal Contraceptives Value Chain

Figure 63. Combined Hormonal Contraceptives Production Process

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Distributors Profiles

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Surrogacy Service Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-3H6190

Wed Apr 17 00:00:00 UTC 2024

Add to Cart

Global Combined Hormonal Contraceptive Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-3P9630

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Male Infertility Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-24Y5897

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

Global Oxytocin Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-35A3544

Mon Apr 15 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions